The histopathology services market is projected to reach US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028.
The histopathology services market is projected to reach US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028.
Histopathology services are used for the microscopic examination of biological tissues in disease diagnosis. With the help of imaging techniques, biopsy tissues can be obtained from certain inaccessible sites, such as pancreas and peritoneum. Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the growth of the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period.
To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00009649/
Here we have listed the top Histopathology Services Market companies
Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC. are among the leading companies operating in the histopathology services market.
Highlights the following key factors:
1) Business description-A detailed description of the company’s operations and business divisions.
2) Corporate strategy – Analyst’s summarization of the company’s business strategy.
3) SWOT Analysis-A detailed analysis of the company’s strengths, weakness, opportunities, and threats.
4) Company history – Progression of key events associated with the company.
5) Major products and services-A list of major products, services, and brands of the company.
6) Key competitors – A list of key competitors to the company.
7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
8) Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 7 years history.
Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Histopathology Services Market which would mention How the Covid-19 is Affecting the Histopathology Services Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Histopathology Services Players to fight Covid-19 Impact.
Based on type of examination, the histopathology services market is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. The surgical specimen segment is estimated to hold the largest share of the market in 2021 and is expected to grow at the highest CAGR during the forecast period. The rising number of biopsy and surgical procedures along with increasing adoption of histopathological tests for diagnosis and interventional studies is expected to propel the growth of the segment in the market during the forecast period.
Chronic diseases such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer are the leading cause of death and disability worldwide. As per the Centers for Disease Control and Prevention, in 2019, nearly 6 in 10 people suffered from at least one chronic disease in the US. As per the World Health Organization (WHO), CVDs are the number one cause of death globally, taking an estimated 17.9 million lives each year.
Cancer is one of the leading causes of mortality worldwide, which acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective treatments for the disease is influencing the market growth. According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers, have increased by 324% in India from 2017 to 2018. Additionally, the total number of patients visiting Non-Communicable Diseases (NCD) clinics have doubled between 2017 and 2018, which is recorded to be 35 million and 66 million, respectively. Rapid change in lifestyle and consumption of alcohol and tobacco products are among the prominent factors increasing the incidences of cancer among the population.
Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00009649/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com